Publisher
Springer Berlin Heidelberg
Reference50 articles.
1. Alberts DS, Dahlberg S, Green SJ, Garcia D, Hannigan EV, O’Toole R, Stock-Novack D, Surwit EA, Malviya VK, Jolles CJ (1993) Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin- cyclophamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study. Cancer 71 [2 Suppl]: 618–627
2. Baak JP, Schipper NW, Wisse-Brekelmans EC, Ceelen T, Bosman FT, van Geuns H, Wils J (1988) The prognostic value of morphometrical features and cellular DNA content in cisplatin treated late ovarian cancer patients. Br J Cancer 57: 503–508
3. Bauknecht T (1993) Die Biologie maligner Ovarialtumoren: Fortschritte und Probleme. In: Meerpohl HG, Pfleiderer A, Profous CZ (eds) Das Ovarialkarzinom 1. Springer, Berlin Heidel¬berg New York, pp 3–6
4. Bertelsen K, Holund B, Andersen JE, Nielsen K, Stroyer I, LadehofT P (1993) Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer 3: 211–218
5. Breitenecker G, Bartl W, Schreiber V (1982) Die Bedeutung verschiedener morphologischer Parameter für die Prognose des Ovarialkarzinoms. In: Dallenbach-Hellweg G (ed) Ovari-altumoren. Springer, Berlin Heidelberg New York
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献